Trial · NCT03054337
Results by group215
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 215
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change in Hemoglobin (Hb) Levels From Pre-treatment to the End of the Primary Efficacy Period | Vadadustat 150 | 0.43 | Standard Error 0.224 | grams per deciliter (g/dL) | |
| Mean Change in Hemoglobin (Hb) Levels From Pre-treatment to the End of the Primary Efficacy Period | Vadadustat 300 mg | 1.13 | Standard Error 0.223 | grams per deciliter (g/dL) | |
| Mean Change in Hemoglobin (Hb) Levels From Pre-treatment to the End of the Primary Efficacy Period | Vadadustat 600 mg | 1.62 | Standard Error 0.215 | grams per deciliter (g/dL) | |
| Mean Change in Hemoglobin (Hb) Levels From Pre-treatment to the End of the Primary Efficacy Period | Placebo | -0.47 | Standard Error 0.206 | grams per deciliter (g/dL) | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Vadadustat 150 mg | 56.8 | Standard Deviation 43.31 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Vadadustat 300 mg | 39.0 | Standard Deviation 38.52 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Vadadustat 600 mg | 25.6 | Standard Deviation 16.47 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Placebo to Vadadustat 150 mg | 79.0 | Standard Deviation 11.31 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Placebo to Vadadustat 300 mg | 71.0 | Standard Deviation 14.00 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Placebo to Vadadustat 600 mg | 54.5 | Standard Deviation 33.67 | days | |
| Mean Hb Levels at the End of the Primary Efficacy Period | Vadadustat 150 mg | 10.392 | Standard Deviation 0.7280 | g/dL | |
| Mean Hb Levels at the End of the Primary Efficacy Period | Vadadustat 300 mg | 10.675 | Standard Deviation 1.2693 | g/dL | |
| Mean Hb Levels at the End of the Primary Efficacy Period | Vadadustat 600 mg | 11.162 | Standard Deviation 1.1169 | g/dL | |
| Mean Hb Levels at the End of the Primary Efficacy Period | Placebo | 9.421 | Standard Deviation 0.9242 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Vadadustat 150 mg | 10.973 | Standard Deviation 0.5711 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Vadadustat 300 mg | 11.230 | Standard Deviation 0.7514 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Vadadustat 600 mg | 11.342 | Standard Deviation 0.6473 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Placebo to Vadadustat 150 mg | 10.860 | Standard Deviation 0.5857 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Placebo to Vadadustat 300 mg | 11.425 | Standard Deviation 0.9179 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Placebo to Vadadustat 600 mg | 11.950 | Standard Deviation 0.6608 | g/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03054337/results